Background
Differentiating between enteric infection and relapse of inflammatory bowel disease (IBD) is a common clinical challenge. Few studies have evaluated the impact of multiplex gastrointestinal polymerase chain reaction (GI PCR) pathogen panels on clinical practice compared to stool culture. Our aim was to compare the impact of PCR stool testing to conventional stool testing in outpatients presenting with relapse of IBD.
Methods
In a retrospective cohort study of outpatients with IBD presenting to NYU Langone Health with flare from September 2015 to April 2019, we compared patients who underwent stool testing with GI PCR to age-, sex-, and IBD-subtype-matched patients who underwent culture and ova and parasite exam (conventional testing). The primary outcome was IBD therapy escalation after testing. Secondary outcomes included rates of posttesting endoscopy, abdominal radiography, antibiotics, and IBD-related emergency department visits, hospitalizations, and abdominal surgeries.
Results
We identified 134 patients who underwent GI PCR matched to 134 patients who underwent conventional testing. Pathogens were more frequently identified on GI PCR (26 vs 5%; P < 0.01). We found that GI PCR was associated with less escalation in IBD therapy (16 vs 29%; P < 0.01) and fewer posttest endoscopies (10% vs 18%; P = 0.04), with no differences in IBD outcomes. On multivariate analysis, testing with GI PCR was associated with an odds ratio of 0.26 (95% confidence interval, 0.08-0.84; P = 0.02) for escalation of IBD therapies.
Conclusions
Testing with GI PCR was associated with higher rates of pathogen detection and lower rates of IBD therapy escalation and endoscopy in the outpatient setting. These changes in management were not associated with a difference in IBD outcomes.
INTRODUCTION:
Patients with obscure gastrointestinal bleeding (OGIB) often require frequent hospital admissions and endoscopic procedures to identify and treat bleeding. Capsule endoscopy (CE) provides a novel approach to evaluate OGIB. The role of inpatient CE in hospital readmissions has not been previously reported. We sought to identify patient and clinical factors associated with hospital readmission among patients with OGIB following inpatient CE.
METHODS:
We conducted a retrospective review of adult patients undergoing inpatient CE at a tertiary referral, academic medical center between 4/1/17 and 4/1/19 to evaluate for predictors of readmission. We reviewed patient demographics, medical history, medications, hospital course, results of CE, and 30-day readmission rates. Arteriovenous malformation (AVM) risk factors were defined as having comorbid cardiac valvular disease or advanced chronic kidney disease (stage 3-5). A positive CE was defined as having abnormal small bowel pathology or bleeding.
RESULTS:
86 patients were included. Overall, 64% were male with a median age of 69 years (Table 1). The main indication for inpatient CE was overt bleeding (59%). Complete CE was noted in 70 patients (81%), and positive CE in 48 patients (56%). Overall, 17 patients (19.8%) were readmitted within 30 days of index admission. Length of stay (LOS) on index admission was longer among those readmitted (Mean LOS 10 days vs 7.9 days, P = 0.07). Readmission was not related to age, gender, complete CE, positive CE or bleeding on CE. There was a trend for readmission among patients who had previously been admitted within 30 days (41% vs 22%, P = 0.1). There was a trend towards readmission for patients with diabetes mellitus (DM) and AVM risk factors. Medication use was not associated with readmission.
CONCLUSION:
Patient with OGIB have high rates of hospital admission. The use of inpatient CE can provide guidance on subsequent therapy in patients with OGIB, with the potential to decrease hospital admissions. We found high rates of 30-day hospital readmission among patients with OGIB after inpatient CE. No significant predictors of readmission were noted, though several factors, including increased LOS on index admission, DM, AVM risk factors, and recent admission trended towards readmission. Larger studies are necessary to fully elucidate predictors of readmission. To our knowledge, this is the first study to address the effect of inpatient CE and hospital readmissions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.